skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 875  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace
Material Type:
Article
Add to My Research

Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace

Journal of clinical laboratory analysis, 2022-09, Vol.36 (9), p.e24655-n/a [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0887-8013 ;EISSN: 1098-2825 ;DOI: 10.1002/jcla.24655 ;PMID: 35949048

Full text available

2
Alzheimer's disease drug development pipeline: 2020
Material Type:
Article
Add to My Research

Alzheimer's disease drug development pipeline: 2020

Alzheimer's & dementia : translational research & clinical interventions, 2020, Vol.6 (1), p.e12050-n/a [Peer Reviewed Journal]

2020 The Authors. published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12050 ;PMID: 32695874

Full text available

3
Alzheimer's disease drug development pipeline: 2021
Material Type:
Article
Add to My Research

Alzheimer's disease drug development pipeline: 2021

Alzheimer's & dementia : translational research & clinical interventions, 2021, Vol.7 (1), p.e12179-n/a [Peer Reviewed Journal]

2021 The Authors. published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2021 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12179 ;PMID: 34095440

Full text available

4
Alzheimer's disease drug development pipeline: 2022
Material Type:
Article
Add to My Research

Alzheimer's disease drug development pipeline: 2022

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12295-n/a [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals, LLC on behalf of Alzheimer's Association ;2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12295 ;PMID: 35516416

Full text available

5
Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
Material Type:
Article
Add to My Research

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products

EMBO molecular medicine, 2017-06, Vol.9 (6), p.737-740 [Peer Reviewed Journal]

2017 The Authors. Published under the terms of the CC BY 4.0 license ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201707573 ;PMID: 28396566

Full text available

6
Radiotherapy–immunotherapy combinations – perspectives and challenges
Material Type:
Article
Add to My Research

Radiotherapy–immunotherapy combinations – perspectives and challenges

Molecular oncology, 2020-07, Vol.14 (7), p.1529-1537 [Peer Reviewed Journal]

2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1574-7891 ;EISSN: 1878-0261 ;DOI: 10.1002/1878-0261.12658 ;PMID: 32112478

Full text available

7
Multifocal Polypseudophakia With Rayner Sulcoflex Trifocal and In-the-Bag Alcon PanOptix Diffractive Trifocal Intraocular Lenses: A Case Report
Material Type:
Article
Add to My Research

Multifocal Polypseudophakia With Rayner Sulcoflex Trifocal and In-the-Bag Alcon PanOptix Diffractive Trifocal Intraocular Lenses: A Case Report

Journal of refractive surgery (1995), 2023-11, Vol.3 (4), p.E53-e55 [Peer Reviewed Journal]

COPYRIGHT 2023 Slack, Inc. ;This work is published under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2768-1599 ;ISSN: 1081-597X ;EISSN: 2768-1599 ;EISSN: 1938-2391 ;DOI: 10.3928/jrscr-20231024-01

Full text available

8
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis
Material Type:
Article
Add to My Research

Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis

Open forum infectious diseases, 2022-07, Vol.9 (7), p.ofac300-ofac300 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022 ;COPYRIGHT 2022 Oxford University Press ;ISSN: 2328-8957 ;EISSN: 2328-8957 ;DOI: 10.1093/ofid/ofac300 ;PMID: 35873302

Full text available

9
Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
Material Type:
Article
Add to My Research

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Open forum infectious diseases, 2019-01, Vol.6 (1), p.ofy331 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2018 ;COPYRIGHT 2019 Oxford University Press ;ISSN: 2328-8957 ;EISSN: 2328-8957 ;DOI: 10.1093/ofid/ofy331 ;PMID: 30648126

Full text available

10
ITP-Pred: an interpretable method for predicting, therapeutic peptides with fused features low-dimension representation
Material Type:
Article
Add to My Research

ITP-Pred: an interpretable method for predicting, therapeutic peptides with fused features low-dimension representation

Briefings in bioinformatics, 2021-07, Vol.22 (4) [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1467-5463 ;EISSN: 1477-4054 ;DOI: 10.1093/bib/bbaa367 ;PMID: 33313672

Full text available

11
Machine learning for synergistic network pharmacology: a comprehensive overview
Material Type:
Article
Add to My Research

Machine learning for synergistic network pharmacology: a comprehensive overview

Briefings in bioinformatics, 2023-05, Vol.24 (3) [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2023 ;The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1467-5463 ;EISSN: 1477-4054 ;DOI: 10.1093/bib/bbad120 ;PMID: 37031957

Full text available

12
Alzheimer's disease drug development pipeline: 2023
Material Type:
Article
Add to My Research

Alzheimer's disease drug development pipeline: 2023

Alzheimer's & dementia : translational research & clinical interventions, 2023-04, Vol.9 (2), p.e12385-n/a [Peer Reviewed Journal]

2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2352-8737 ;EISSN: 2352-8737 ;DOI: 10.1002/trc2.12385 ;PMID: 37251912

Full text available

13
Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China
Material Type:
Article
Add to My Research

Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China

Journal of cellular and molecular medicine, 2019-01, Vol.23 (1), p.4-20 [Peer Reviewed Journal]

2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13564 ;PMID: 30444050

Full text available

14
Tamiflu, clinical trials and the Public Accounts Committee
Material Type:
Article
Add to My Research

Tamiflu, clinical trials and the Public Accounts Committee

Prescriber (London, England), 2014-06, Vol.25 (11), p.28-29 [Peer Reviewed Journal]

Copyright © 2014 Wiley Interface Ltd ;ISSN: 0959-6682 ;EISSN: 1931-2253 ;DOI: 10.1002/psb.1214

Full text available

15
Health system efficiency in Germany: results of a pilot study to assess health system performance
Material Type:
Article
Add to My Research

Health system efficiency in Germany: results of a pilot study to assess health system performance

European journal of public health, 2022-10, Vol.32 (Supplement_3) [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. ;ISSN: 1101-1262 ;EISSN: 1464-360X ;DOI: 10.1093/eurpub/ckac131.024

Full text available

16
5.M. Workshop: The need to account for vaccine-specificities in the implementation of the EU Regulation on HTA
Material Type:
Article
Add to My Research

5.M. Workshop: The need to account for vaccine-specificities in the implementation of the EU Regulation on HTA

European journal of public health, 2022-10, Vol.32 (Supplement_3) [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. ;ISSN: 1101-1262 ;EISSN: 1464-360X ;DOI: 10.1093/eurpub/ckac129.326

Full text available

17
Coronavirus Disease 2019–Associated Invasive Fungal Infection
Material Type:
Article
Add to My Research

Coronavirus Disease 2019–Associated Invasive Fungal Infection

Open forum infectious diseases, 2021-12, Vol.8 (12), p.ofab510-ofab510 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2021 ;COPYRIGHT 2021 Oxford University Press ;ISSN: 2328-8957 ;EISSN: 2328-8957 ;DOI: 10.1093/ofid/ofab510 ;PMID: 34877364

Full text available

18
Rhamnolipids produced by Pseudomonas: from molecular genetics to the market
Material Type:
Article
Add to My Research

Rhamnolipids produced by Pseudomonas: from molecular genetics to the market

Microbial biotechnology, 2021-01, Vol.14 (1), p.136-146 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2020 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1751-7915 ;EISSN: 1751-7915 ;DOI: 10.1111/1751-7915.13700 ;PMID: 33151628

Full text available

19
Public preference for COVID‐19 vaccines in China: A discrete choice experiment
Material Type:
Article
Add to My Research

Public preference for COVID‐19 vaccines in China: A discrete choice experiment

Health expectations : an international journal of public participation in health care and health policy, 2020-12, Vol.23 (6), p.1543-1578 [Peer Reviewed Journal]

2020 The Authors published by John Wiley & Sons Ltd ;2020 The Authors Health Expectations published by John Wiley & Sons Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1369-6513 ;EISSN: 1369-7625 ;DOI: 10.1111/hex.13140 ;PMID: 33022806

Full text available

20
Biochemistry, genetics and biotechnology of glycerol utilization in Pseudomonas species
Material Type:
Article
Add to My Research

Biochemistry, genetics and biotechnology of glycerol utilization in Pseudomonas species

Microbial biotechnology, 2020-01, Vol.13 (1), p.32-53 [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1751-7915 ;EISSN: 1751-7915 ;DOI: 10.1111/1751-7915.13400 ;PMID: 30883020

Full text available

Results 1 - 20 of 875  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (873)

Refine My Results

Creation Date 

From To
  1. Before 1991  (13)
  2. 1991 To 2000  (29)
  3. 2001 To 2008  (81)
  4. 2009 To 2016  (135)
  5. After 2016  (618)
  6. More options open sub menu

Language 

  1. Japanese  (68)
  2. Italian  (4)
  3. Norwegian  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait